Tsvetanova Promoted to Associate Professor with Tenure
Nina Tsvetanova, PhD, has been promoted to Associate Professor with tenure, effective July 1, 2026.
Alumni spotlight on Trudy G. Oliver, PhD: good science always matters
The lab of Trudy G. Oliver, PhD, a professor of pharmacology and cancer biology at Duke University School of Medicine and PCB alumna, focuses on cancer cell identity and lineage plasticity —understanding how developmental programs govern cell state, differentiation, and therapeutic vulnerabilities in cancer. Last year, her team made a discovery that marked a major shift in understanding of the origins of small cell lung cancer.
Team led by Andrew West joins global network to unravel the complexity of Parkinson’s disease
A research team led by Andrew West, PhD, professor of pharmacology and cancer biology at Duke, has been selected to join the Collaborative Research Network, an international, multidisciplinary, multi-institutional network working to address high-priority research questions about Parkinson's disease, through a $9 million grant awarded by Aligning Science Across Parkinson’s (ASAP), in partnership with The Michael J. Fox Foundation for Parkinson’s Research.
Haystead receives inaugural Neil L. Spector, MD, Legacy Award for Transformational Lyme and Tick-Borne Disease Research
Timothy Haystead, PhD, professor of pharmacology and cancer biology, has been honored with the inaugural Neil L. Spector, MD, Legacy Award for Transformational Lyme and Tick-Borne Disease Research, from the Bay Area Lyme Foundation. The award is the foundation’s highest scientific honor, recognizing bold, rigorous, translational research that moves patients closer to answers.
